Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00491738
Status:
TERMINATED
Last Update Posted:
2009-04-10
First Post:
2007-06-25
Brief Title:
A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer SABRE-R
Sponsor:
Organization:
Genentech Inc